COR
Cencora
$308.56
▼ -0.89%
−$2.78
NYSE · Healthcare · Medical Distribution
· price updated 9h ago
Cencora
COR · NYSE · Healthcare · Medical Distribution · price updated 9h ago
$308.56
▼ -0.89% · −$2.78 today
AI research · $308.56
Track COR for continuous AI research
price position
Where COR sits now
52-week range
Low$244.82
High$377.54
Today $308.56
RSI (14)
53.5Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$2.2B
Total debt$12.4B
Net cash after debt$-10.2B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Favorable · 19% below Sector avg · favorable
16.72x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
0.18x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
38.88x
EV / EBITDA
Operating value including debt
Reasonable · Between 12x and 22x EBITDA
19.14x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
23.2%
ROE
Profit generated from shareholder equity
Favorable · Exceptional vs sector peers
107.1%
Debt / equity
Balance-sheet leverage
Needs attention · Among weakest in sector
4.21x
Current ratio
Short-term assets against liabilities
Weak · Near-term liabilities exceed current assets
0.95x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How COR compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $60.57B | 23.9 | +6.0% | 71 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
upcoming earnings
earnings calendar →Aug 5
Wall Street EPS estimate: 4.38. Add COR to Radar so the earnings setup can bring you back when it matters.
activity
What is moving COR
US stock research
About Cencora (COR) stock
Cencora — US core universe (S&P 500 sourced). COR was -0.9% in the latest available session at $308.56. Its reported market value was $60.57B with a trailing P/E of 23.9. Latest reported revenue was $328.68B, changing +6.0% year over year, with $2.55B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $308.56
- Day change
- -0.9%
- Market cap
- $60.57B
- P/E (TTM)
- 23.9
- Revenue growth
- +6.0%
- Industry
- Medical Distribution